Stock Analyst News: OpenTable,, Kinross Gold, Walgreen, Calpine

OpenTable, Inc. (NASDAQ:OPEN): Collins Stewart believes OpenTable’s Q4 results prove investor concerns regarding a growth slowdown and increasing competition are overblown. The firm thinks OpenTable’s operating leverage is being underestimated and reiterates a Buy rating on the stock with a $93 price target. (NYSE:CRM): Citigroup expects to report 30%-plus year-over-year billings growth in the January quarter. The firm maintains a Buy rating on the stock with a $152 price target.

Kinross Gold Corporation (NYSE:KGC): Kinross Gold added to short-term buy list at Deutsche Bank

Walgreen Co. (NYSE:WAG): Jefferies says Walgreens (NYSE:WAG) indicated to the firm during a visit to the company’s headquarters that coming to an agreement with Express Scripts (NASDAQ:ESRX) is not in its best interest since the damage to its business has already been realized. Walgreens is very confident that Express Scripts will lose significant business as the 2013 selling season progresses, leading to business returning back to the company over the next 18 months, Jefferies added. Further, Jefferies states that Walgreen management feels that its partners Catalyst (NASDAQ:CHSI) and MedImpact are likely to win significant business, as is CVS Caremark (NYSE:CVS).

Calpine Corp. (NYSE:CPN): Calpine named a long Research Tactical Idea at Morgan Stanley

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at